Monitoring the properties of 1,2,4-triazole derivatives for the development of original antimicrobial drugs
DOI:
https://doi.org/10.14739/2310-1210.2024.6.309034Keywords:
1,2,4-triazole, biological activity, antimicrobial effect, in silico, in vitroAbstract
Aim. A comprehensive study on the antimicrobial properties of new 1,2,4-triazole derivatives using the tools of in silico and in vitro studies.
Materials and methods. Computer search techniques were used to find a compound with a strong antibacterial activity; in silico molecular docking (receptors for class A (PDB id: 1n9b) and class A SHV-1 (PDB id: 2zd8) beta-lactamase) and in vitro studies on 16 types of microorganisms. Then, the in silico analyzed compounds were tested in vitro for antimicrobial activity. After preparing solutions of different concentrations, the culture growth was measured on a zonal scale for detecting sizes of microbial growth inhibition zones after 24 hours (Antibiotic Zone Scale-C, model RW297, India) and a TpsDig2 software (2016, F. James Rohlf). Statistical analysis of the study results was carried out using the Statistica 13 software (StatSoft Inc., USA).
Results. From the results of molecular docking, a strong binding affinity to class A enzymes has been found in compounds 2, 7, so they could be effective in the treatment of infection caused by K. pneumoniae. The ascending order of the predicted binding affinity through the calculated score for TEM and SHV enzymes was as follows: compound 4 < compound 3 < compound 1 < compound 7 < compound 2. According to our results, the studied chemical compounds 1–4, 7 inhibited the growth of many microbial species of the Enterobacteriaceae, Morganellaceae, Pseudomonadaceae, Enterococcaceae, Staphylococcaceae and Bacillaceae families.
Conclusions. For the first time, studies on the complex inhibitory effect of chemical compounds 1–4, 7 were conducted using 16 bacterial strains. Evident antibacterial effects of the studied compounds have been established: compound 1 against 13, compound 2 – 9, compound 3 – 10, compound 4 – 7, compound 7 – 10 out of 16 tested polyresistant bacterial strains.
References
Morandi S, Silvetti T, Lopreiato V, Piccioli-Cappelli F, Trevisi E, Brasca M. Biodiversity and antibiotic resistance profile provide new evidence for a different origin of enterococci in bovine raw milk and feces. Food Microbiol. 2024;120:104492. doi: https://doi.org/10.1016/j.fm.2024.104492
Tian G, Song Q, Liu Z, Guo J, Cao S, Long S. Recent advances in 1,2,3- and 1,2,4-triazole hybrids as antimicrobials and their SAR: A critical review. Eur J Med Chem. 2023;259:115603. doi: https://doi.org/10.1016/j.ejmech.2023.115603
Mancuso G, Midiri A, Gerace E, Biondo C. Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens. 2021;10(10):1310. doi: https://doi.org/10.3390/pathogens10101310
Poia A. Cherez viinu v Ukraini zroste tiazhkist ta poshyrenist deiakykh infektsiinykh khvorob - VOOZ [Due to the war in Ukraine, the severity and prevalence of some infectious diseases will increase - WHO]. Ukrainska pravda. 2023 Nov 7 [cited 2024 Oct 16]. Available from: https://life.pravda.com.ua/health/2023/11/7/257504/
Xie F, Ni T, Zhao J, Pang L, Li R, Cai Z, et al. Design, synthesis, and in vitro evaluation of novel antifungal triazoles. Bioorg Med Chem Lett. 2017;27(10):2171-3. doi: https://doi.org/10.1016/j.bmcl.2017.03.062
El‐Sebaey SA. Recent advances in 1,2,4-triazole scaffolds as antiviral agents. Chemistry Select. 2020;5(37):11654-80. doi: https://doi.org/10.1002/slct.202002830
Morakinyo AE, Oyebamiji AK, Morddiyyah A, Chukwuetoo CC, Oyedapo OO. Antioxidant and anti-inflammatory activities of methanolicpulp residue extract of african star apple (Chrysophyllum albidum). Lett Appl Nanobiosci. 2024;13(1):1-9. doi: https://doi.org/10.33263/LIANBS131.035
Ibrahim AO, Semire B, Oladuji TE, Latona DF, Oyebamiji AK, Owonikoko AD, et al. Molecular properties and in silico bioactivity evaluation of (4-fluorophenyl)[5)-3-phen-(4-nitrophenyl yl-4,5-dihydro-1H-pyrazol-1-yl]methanone derivatives: DFT and molecular docking approaches. J Taibah Univ Med Sci. 2023;18(6):1386-405. doi: https://doi.org/10.1016/j.jtumed.2023.05.011
Nukaga M, Mayama K, Hujer AM, Bonomo RA, Knox JR. Ultrahigh resolution structure of a class A beta-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme. J Mol Biol. 2003;328(1):289-301. doi: https://doi.org/10.1016/s0022-2836(03)00210-9
Nukaga M, Bethel CR, Thomson JM, Hujer AM, Distler A, Anderson VE, et al. Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1. J Am Chem Soc. 2008;130(38):12656-62. doi: https://doi.org/10.1021/ja7111146
Davydenko P, Borovik I, Kulishenko O, Zazharskyi V, Radzykhovskyі M, Dyshkant, O, et al. [Tuberculocidal and tuberculostаtic activity of 1,2,4-triazole derivatives in vitro (determination of mic (minimum inhibitory concentration)]. Scientific and technical bulletin оf state scientific research control institute of veterinary medical products and fodder additives аnd institute of animal biology. 2023;24(2):59-71. Ukrainian. doi: https://doi.org/10.36359/scivp.2023-24-2.07
Karpenko Y, Kusdemir G, Parchenko V, Tüzün B, Taslimi P, Karatas OF, et al. A Biochemistry‐oriented Drug Design: Synthesis, Anticancer Activity, Enzymes Inhibition, Molecular Docking Studies of Novel 1,2,4-Triazole Derivatives. J Biomol Struct Dyn. 2023;42(3):1220-36. doi: https://doi.org/10.1080/07391102.2023.2253906
CLSI M100-S21 - Performance Standards for Antimicrobial Susceptibility Testing; Twenty First Informational Supplement [Internet]. Ansi.org. 2024 [cited 2024 Oct 16]. Available from: https://webstore.ansi.org/standards/clsi/clsim100s21?srsltid=AfmBOor7rMkHiPcNa65N7eDSmwJ2SSW4aBK7FKL6N-5qTGVYFj1BnodU
Akinola OT, Oyebamiji AK, Oke DG. In silico analysis on binding action of beta-lactam drugs against TEM and SHV class A beta-lactamases from Klebsiella pneumoniae. Discov Appl Sci. 2024;6(196):1-10. doi: https://doi.org/10.1007/s42452-024-05783-8
Czatzkowska M, Wolak I, Harnisz M, Korzeniewska E. Impact of anthropogenic activities on the dissemination of ARGs in the environment-a review. Int J Environ Res Public Health. 2022;19(19):12853. doi: https://doi.org/10.3390/ijerph191912853
Karpun Y, Fedotov S, Khilkovets A, Karpenko Y, Parchenko V, Klochkova Y, et al. An in silico investigation of 1,2,4-triazole derivatives as potential antioxidant agents using molecular docking, MD simulations, MM-PBSA free energy calculations and ADME predictions. Pharmacia. 2023;70(1):139-53. doi: https://doi.org/10.3897/pharmacia.70.e90783
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
